Literature DB >> 32352188

Inhibition of Human Breast Cancer Cell Proliferation by Low-Intensity Ultrasound Stimulation.

Amit Katiyar1, Jenna Osborn2, Malaya DasBanerjee1, Lijie Grace Zhang2, Kausik Sarkar2, Krishna Pada Sarker1.   

Abstract

OBJECTIVES: Cancer is characterized by uncontrolled cell proliferation, which makes novel therapies highly desired. In this study, the effects of near-field low-intensity pulsed ultrasound (LIPUS) stimulation on T47D human breast cancer cell and healthy immortalized MCF-12A breast epithelial cell proliferation were investigated in monolayer cultures.
METHODS: A customized ultrasound (US) exposure setup was used for the variation of key US parameters: intensity, excitation duration, and duty cycle. Cell proliferation was quantified by 5-bromo-2'-deoxyuridine and alamarBlue assays after LIPUS excitation.
RESULTS: At a 20% duty cycle and 10-minute excitation period, we varied LIPUS intensity from to 100 mW/cm2 (spatial-average temporal-average) to find a gradual decrease in T47D cell proliferation, the decrease being strongest at 100 mW/cm2 . In contrast, healthy MCF-12A breast cells showed an increase in proliferation when exposed to the same conditions. Above a 60% duty cycle, T47D cell proliferation decreased drastically. Effects of continuous wave US stimulation were further explored by varying the intensity and excitation period.
CONCLUSIONS: These experiments concluded that, irrespective of the waveform (pulsed or continuous), LIPUS stimulation could inhibit the proliferation of T47D breast cancer cells, whereas the same behavior was not observed in healthy cells. The study demonstrates the beneficial bioeffects of LIPUS on breast cancer cells and offers the possibility of developing novel US-mediated cancer therapy.
© 2020 by the American Institute of Ultrasound in Medicine.

Entities:  

Keywords:  T47D; breast cancer; low-intensity pulsed ultrasound; proliferation; therapy

Mesh:

Year:  2020        PMID: 32352188     DOI: 10.1002/jum.15312

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  2 in total

1.  RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS/STING signaling pathway in lung adenocarcinoma.

Authors:  Xueping Jiang; Yangyi Li; Nannan Zhang; Yanping Gao; Linzhi Han; Shuying Li; Jiali Li; Xingyu Liu; Yan Gong; Conghua Xie
Journal:  Cell Biosci       Date:  2021-04-15       Impact factor: 9.584

2.  Synergistic enhancement of cell death by triple combination therapy of docetaxel, ultrasound and microbubbles, and radiotherapy on PC3 a prostate cancer cell line.

Authors:  Firas Almasri; Raffi Karshafian
Journal:  Heliyon       Date:  2022-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.